news-details
Health,Health Technology,Health Services,Watchlist

4 HealthTech Stocks up over 30% past 10 days (ANVS stock, MHUA stock, FUSN stock, IDYA stock)

Today, the screeners at HealthTechMovers.com picked up 4 HealthTech Stocks up over 30% past 10 days and have been added to our watchlist.  These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.

MarketMoversInsider.com is also looking into these tickers BMRN, PEPG, BLCO, COO, SAGE.

One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com. 

Annovis Bio, ANVS

Summary: Annovis Bio Inc. is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease, Parkinson's disease and Alzheimer's in Down Syndrome. Annovis Bio Inc. is headquartered in Berwyn, Pennsylvania.
Recent ANVS Stock Price (approx 10:00am EST.): $16.85
Previous Close for ANVS Stock: $15.87
Percentage Price Change Past 10 Days for ANVS stock: +55% 

TipRanks.com reports that Annovis Bio stock currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for ANVS stock with an average price target is $33.00. 

Click here to get the full story on ANVS stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Meihua International Medical Technologies Co., Ltd., MHUA
Summary: Meihua International Medical Technologies Co., Ltd. is a manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries principally in China. The Company manufactures and sells Class I such as eye drops bottle, medicine bottle anal bag etc., Class II and III disposable medical devices such as identification tape, gynecological examination kits, inspection kits, surgical kits, medical brushes, medical dressing, masks, disposable infusion pumps, electronic pumps, puncture kits, etc. under their own brands and also distribute such disposable medical devices sourced from other manufacturers.
Recent MHUA Stock Price (approx 10:00am EST.): $6.34
Previous Close for MHUA Stock: $6
Percentage Price Change Past 10 Days for MHUA stock: +33% 

Click here to get the full story on MHUA stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Fusion Pharmaceuticals, FUSN
Summary: Fusion Pharmaceuticals Inc. is a clinical-stage oncology company focused on developing radiopharmaceuticals as precision medicines. The compnay's lead program includes FPI-1434, which is in clinical trial. Fusion Pharmaceuticals Inc. is based in Hamilton, Canada.
Recent FUSN Stock Price (approx 10:00am EST.): $3.16
Previous Close for FUSN Stock: $3.28
Percentage Price Change Past 10 Days for FUSN stock: +31% 

TipRanks.com reports that Fusion Pharmaceuticals stock currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating for FUSN stock with an average price target is $10.67. 

Click here to get the full story on FUSN stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

IDEAYA Biosciences, IDYA
Summary: IDEAYA Biosciences Inc. is an oncology-focused precision medicine company. It focuses on the discovery and development of therapeutics for patients using molecular diagnostics. The company's product pipeline consists of IDE196, MAT2A, PARG, Pol-theta and WRN which are in clinical stage. IDEAYA Biosciences Inc. is based in South San Francisco, United States.
Recent IDYA Stock Price (approx 10:00am EST.): $12.11
Previous Close for IDYA Stock: $11.92
Percentage Price Change Past 10 Days for IDYA stock: +30% 

TipRanks.com reports that IDEAYA Biosciences stock currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating for IDYA stock with an average price target is $20.60. 

Click here to get the full story on IDYA stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com.

The other great tool for charting is TradingView.com, so you might want to check that out too.

The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.

MarketMoversInsider.com is for serious traders.